2002
DOI: 10.1016/s0022-1759(02)00015-7
|View full text |Cite
|
Sign up to set email alerts
|

Advantages of hydrophobic culture bags over flasks for the generation of monocyte-derived dendritic cells for clinical applications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
28
0

Year Published

2003
2003
2020
2020

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 28 publications
(28 citation statements)
references
References 24 publications
0
28
0
Order By: Relevance
“…Human DCs were generated using a standard protocol of leukapheresis, countercurrent elutriation, and differentiation of the monocyte fraction with GM-CSF and IL-4 for 7 d (Guyre et al 2002). The resulting immature DCs were split with half receiving LPS (2.5 mg/mL) and CD40L (10 mg/mL) for 24 h, and half left untreated.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Human DCs were generated using a standard protocol of leukapheresis, countercurrent elutriation, and differentiation of the monocyte fraction with GM-CSF and IL-4 for 7 d (Guyre et al 2002). The resulting immature DCs were split with half receiving LPS (2.5 mg/mL) and CD40L (10 mg/mL) for 24 h, and half left untreated.…”
Section: Resultsmentioning
confidence: 99%
“…Differentiation: Monocytes were incubated in VueLife bags in RPMI containing 10% FCS and GM-CSF (10 ng/mL) and IL-4 (20 ng/mL) for 7 d, receiving additional GM-CSF and IL-4 as above on day 4 (Guyre et al 2002). Maturation: iDCs were harvested, washed, and cultured in the presence of LPS (2.5 mg/mL) and CD40L (10 mg/mL), for 24 h at 37°C in VueLife bags.…”
Section: Generation and Maturation Of Dendritic Cellsmentioning
confidence: 99%
“…Although for the clinical application of DCs the culture will need to take place in a fully enclosed system, for instance cell bags (Guyre et al 2002). Because of the simplicity of the protocol described here the transfer to such a system should be easily achieved.…”
Section: Discussionmentioning
confidence: 99%
“…In view of existing reports describing also the serumfree culture of DCs for clinical application [5,8,9] and because of potential disadvantages associated with the use of serum such as lot to lot variability and the presence of undefined serum factors, we considered DC culture in serumfree AIMV medium as an attractive alternative. However, from existing literature, we missed a conclusive direct comparison of such differently cultured DCs.…”
Section: Discussionmentioning
confidence: 99%
“…Both autologous as well as allogeneic serum derived from the patients or healthy donors, respectively, potentially introduce undefined ingredients with variable effects on DC function together with a lot to lot variability to the culture system. Serumfree culture of monocyte-derived DCs has been reported with media such as XVivo15, XVivo20 and AIMV [2][3][4][5][6][7][8][9][10]. From these reports, however, we could not deduce whether DCs cultured under such conditions are functionally equivalent to DCs cultured in the presence of human serum.…”
Section: Introductionmentioning
confidence: 87%